AAAAAA
Results: 1-25/28
Authors:
Levine, DA
Barakat, RR
Citation: Da. Levine et Rr. Barakat, Gynecologic malignancies in older women - The Mirhashemi/Nieves-Neira/Averette article reviewed, ONCOLOGY-NY, 15(5), 2001, pp. 592-593
Authors:
Chi, DS
Jones, WB
Barakat, RR
O'Keefe, KN
Hoskins, WJ
Lewis, JL
Citation: Ds. Chi et al., The benefit of a special elective gynecologic oncology program for obstetrics and gynecology residents, EUR J GYN O, 22(4), 2001, pp. 266-268
Authors:
Gemignani, ML
Alektiar, KM
Leitao, M
Mychalczak, B
Chi, D
Venkatraman, E
Barakat, RR
Curtin, JP
Citation: Ml. Gemignani et al., Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers, INT J RAD O, 50(3), 2001, pp. 687-694
Authors:
Harlap, S
Olson, S
Akhmedkhanov, A
Barakat, RR
Caputo, T
Sanchez, D
Xue, X
Citation: S. Harlap et al., Epithelial ovarian carcinoma and European birthplace of grandparents, GYNECOL ONC, 81(1), 2001, pp. 25-32
Authors:
Sonoda, Y
Zerbe, M
Smith, A
Lin, O
Barakat, RR
Hoskins, WJ
Citation: Y. Sonoda et al., High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy, GYNECOL ONC, 80(3), 2001, pp. 378-382
Authors:
Levine, DA
Lin, O
Barakat, RR
Robson, ME
McDermott, D
Cohen, L
Satagopan, J
Offit, K
Boyd, J
Citation: Da. Levine et al., Risk of endometrial carcinoma associated with BRCA mutation, GYNECOL ONC, 80(3), 2001, pp. 395-398
Authors:
Gemignani, ML
Hensley, ML
Cohen, R
Venkatraman, E
Saigo, PE
Barakat, RR
Citation: Ml. Gemignani et al., Paclitaxel-based chemotherapy in carcinoma of the Fallopian tube, GYNECOL ONC, 80(1), 2001, pp. 16-20
Authors:
Husain, A
Chi, DS
Prasad, M
Abu-Rustum, N
Barakat, RR
Brown, CL
Poynor, EA
Hoskins, WJ
Curtin, JP
Citation: A. Husain et al., The role of laparoscopy in second-look evaluations for ovarian cancer, GYNECOL ONC, 80(1), 2001, pp. 44-47
Authors:
Olson, SH
Mignone, L
Nakraseive, C
Caputo, TA
Barakat, RR
Harlap, S
Citation: Sh. Olson et al., Symptoms of ovarian cancer, OBSTET GYN, 98(2), 2001, pp. 212-217
Authors:
Gu, M
Shi, WJ
Barakat, RR
Thaler, HT
Saigo, PE
Citation: M. Gu et al., Pap smears in women with endometrial carcinoma, ACT CYTOL, 45(4), 2001, pp. 555-560
Authors:
Barakat, RR
Citation: Rr. Barakat, Should women receiving tamoxifen for breast cancer be screened for endometrial cancer?, CANCER INV, 18(8), 2000, pp. 796-797
Authors:
Barakat, RR
Gilewski, TA
Almadrones, L
Saigo, PE
Venkatraman, E
Hudis, C
Hoskins, WJ
Citation: Rr. Barakat et al., Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: A prospective study using office endometrial biopsy, J CL ONCOL, 18(20), 2000, pp. 3459-3463
Authors:
Barakat, RR
Citation: Rr. Barakat, Tamoxifen and endometrial screening - Reply 2, J CL ONCOL, 18(2), 2000, pp. 448-448
Authors:
Boyd, J
Sonoda, Y
Federici, MG
Bogomolniy, F
Rhei, E
Maresco, DL
Saigo, PE
Almadrones, LA
Barakat, RR
Brown, CL
Chi, DS
Curtin, JP
Poynor, EA
Hoskins, WJ
Citation: J. Boyd et al., Clinicopathologic features of BRCA-linked and sporadic ovarian cancer, J AM MED A, 283(17), 2000, pp. 2260-2265
Authors:
Gu, M
Shi, WJ
Huang, JT
Barakat, RR
Thaler, HT
Saigo, PE
Citation: M. Gu et al., Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma, CANC CYTOP, 90(3), 2000, pp. 143-147
Authors:
Barakat, RR
Federici, MG
Saigo, PE
Robson, ME
Offit, K
Boyd, J
Citation: Rr. Barakat et al., Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes, CANCER, 89(2), 2000, pp. 383-390
Authors:
Gu, M
Shi, WJ
Barakat, RR
Thaler, HT
Saigo, PE
Citation: M. Gu et al., Peritoneal washings in endometrial carcinoma - A study of 298 patients with histopathologic correlation, ACT CYTOL, 44(5), 2000, pp. 783-789
Authors:
Abadi, MA
Barakat, RR
Saigo, PE
Citation: Ma. Abadi et al., Effects of tamoxifen on cervicovaginal smears from patients with breast cancer, ACT CYTOL, 44(2), 2000, pp. 141-146
Authors:
Sonoda, Y
Barakat, RR
Citation: Y. Sonoda et Rr. Barakat, Molecular pathogenesis of endometrial cancer - The role of tamoxifen, CONT ENDOC, 2000, pp. 325-335
Authors:
Barakat, RR
Spriggs, DR
Citation: Rr. Barakat et Dr. Spriggs, Memorial Sloan-Kettering Cancer Center experience with intraperitoneal chemotherapy of ovarian cancer, CUR CLIN ON, 2, 2000, pp. 167-177
Authors:
Makhija, S
Sabbatini, P
Barakat, RR
Citation: S. Makhija et al., Intraperitoneal chemotherapy strategies in the treatment of epithelial ovarian carcinoma, CUR OP OBST, 11(1), 1999, pp. 23-27
Authors:
Barakat, RR
Citation: Rr. Barakat, Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer, J CL ONCOL, 17(7), 1999, pp. 1967-1968
Authors:
Chi, DS
Waltzman, RJ
Barakat, RR
Spriggs, DR
Citation: Ds. Chi et al., Primary intravenous paclitaxel and platinum chemotherapy for high-risk Stage I epithelial ovarian carcinoma, EUR J GYN O, 20(4), 1999, pp. 277-280
Authors:
Barakat, RR
Goldman, NA
Patel, DA
Venkatraman, ES
Curtin, JP
Citation: Rr. Barakat et al., Pelvic exenteration for recurrent endometrial cancer, GYNECOL ONC, 75(1), 1999, pp. 99-102
Authors:
Gemignani, ML
Curtin, JP
Zelmanovich, J
Patel, DA
Venkatraman, E
Barakat, RR
Citation: Ml. Gemignani et al., Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: Clinical outcomes and hospital charges, GYNECOL ONC, 73(1), 1999, pp. 5-11